Your session is about to expire
← Back to Search
Smartphone Apps for Opioid Use Disorder
Study Summary
This trial would use apps to help prevent relapse among patients receiving treatment for opioid use disorder. The apps would track the person's location and offer targeted, personalized intervention when they enter an area at high risk for relapse.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am either male or female.I am either male or female.I am in the initial phase of treatment for opioid addiction, receiving weekly medication.I am 18 years old or older.I have no history of serious neurological, heart diseases, infections, or significant brain injuries.I am between 18 and 50 years old.You must be a native English speaker to participate in the MRI sub-study.I am 18 years old or older.I am willing to use a smartphone for the study if needed.I am between 18 and 50 years old.I am in the initial phase of treatment for opioid addiction, receiving weekly medication.I am willing to use a smartphone for the study if needed.(MRI sub-study): You must be fluent in English.
- Group 1: Smartphone
- Group 2: Monitoring Only
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this experimental protocol currently enrolling participants?
"The information found on clinicaltrials.gov suggests that this particular trial, which was initially posted in November 2022 and updated last month, is not recruiting patients currently. However, there are 347 other studies actively looking for participants presently."
What risks do individuals face when utilizing smartphones?
"While the efficacy of Smartphone is yet to be determined, prior clinical data suggests that it's safety rating should stand at 2 on our scale."
What is the ultimate aim of this research?
"The primary objective to be observed over roughly 23 weeks is a urinalysis at intake. Secondary aims include the TLFB - Month 6, which assesses how many days in the past month there has been self-reported opioid misuse, Treatment Continuation - Week 8 and 16 binary variables indicating if patients are still receiving treatment or not, with survival analysis employed to determine whether duration of treatment differs by study arm."
Who else is applying?
What state do they live in?
How old are they?
What portion of applicants met pre-screening criteria?
What site did they apply to?
Share this study with friends
Copy Link
Messenger